Creating a center to advance new technologies for nervous system disorders
Official title: Center for Innovative NeuroTech Advancement - CINTA
Funded at Massachusetts General Hospital · NIH-11181982 · Data updated 2026-11-12
This study is all about finding new and better ways to help people with nervous system disorders by using the latest technology, and it's designed for patients who are looking for innovative treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $2,940,899 |
| NIH project number | 3U54EB033650-03S4 |
| Project ID | NIH-11181982 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals diagnosed with various neurological disorders seeking innovative treatment options.
✕Less likely to help
Patients with stable neurological conditions that do not require new interventions may not receive direct benefits from this research.
What this research studies
The Center for Innovative NeuroTech Advancement (CINTA) aims to transform emerging technologies into practical solutions for disorders affecting the nervous system. This initiative will leverage decades of experience in managing multi-disciplinary research to identify unmet medical needs and develop technology-based projects that address these needs. Patients can expect innovative approaches to treatment as the center focuses on rapid development and commercialization of new healthcare technologies. The research will involve collaboration among various institutions and experts to ensure that the solutions are clinically relevant and effective.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking treatments and technologies that significantly improve the quality of life for patients with neurological disorders.
How similar studies have gone: Previous initiatives in healthcare technology innovation have shown success in transforming concepts into viable treatments, suggesting a strong potential for this approach.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Schachter, Steven C. — Massachusetts General Hospital
- Study coordinator: Schachter, Steven C.
Related research
Other NIH-funded projects on the same topics.
-
Global TravEpiNet: Pregnant Travelers Health and Disease Prevention Network
This grant supports a national network to improve health and prevent infections among international travelers, with a special focus on pregnant travelers.
-
Soluble ST2 and the course of lung injury in ARDS
A doctor-scientist at a top hospital is studying how a molecule called soluble ST2 may influence how lung injury starts and heals in patients with ARDS and related conditions.
-
Role of airway macrophages in lung health and allergic disease
A doctor-scientist at a major hospital wants to study how immune cells in the airways develop and influence asthma and other airway diseases.
-
Global TravEpiNet: Understanding and Protecting US Travelers, including Pregnant Travelers
A large U.S. network studies international travelers, including pregnant travelers, to understand illness risks and reduce the spread of infections.
-
Gait speed from wearable sensors to guide ALS trials
A patient-friendly look at using wearable sensors to measure how fast people with ALS walk, to help run better ALS trials.
-
Determinants of Post-Stroke Cognitive Outcomes and Vascular Effects on Recovery
A large, multi-site effort aims to understand why some stroke survivors develop long-term cognitive problems and dementia, and how vascular health and pre-existing brain changes influence recovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.